Objective: We evaluated a novel scintigraphic method employing new parameters of mechanical left ventricular (LV) dyssynchrony and correlated it with clinical outcomes in heart failure patients with reduced ejection fraction (HFrEF) receiving cardiac resynchronization therapy (CRT).
either LVS <0.84 or IVS ≥18.8° as opposed to only 16% of non-responders (p =0.001). 29 of 32(91%) patients with either of these measures responded to CRT (p < 0.01). 
Conclusions

Introduction
Heart failure (HF) is the most frequent cause of cardiac hospitalization in the USA, effecting 5,000,000 patients with 250,000 deaths yearly (1) . Both ventricular systolic function and synchrony have been shown to have significant prognostic impact in HF (2, 3) . Cardiac resynchronization therapy (CRT) has been proven to reduce both the morbidity and mortality of HF patients who become refractory to medications and present with a wide QRS (2) (3) (4) . However, improvement of HF with CRT based on clinical and echocardiographic criteria is highly variable with 30% -40% patients who do not improve or worsen with CRT (2) (3) (4) (5) .
Scintigraphic methods that image myocardial perfusion and function have been adapted for synchrony analysis (6, 7) . SPECT myocardial perfusion scintigraphy combines measures of both perfusion and function and extracted parameters have been demonstrated to measure ventricular synchrony and even to predict CRT outcomes (8, 9) . Equilibrium radionuclide angiography (ERNA) has advantages of higher temporal resolution, greater reproducibility, and volumetric analysis of both ventricles that can be applied for analysis of intra-ventricular and inter-ventricular synchrony (7, 10) .
Novel, objective measures of regional contraction and global mechanical synchrony based on the first harmonic fit of the ERNA ventricular time versus radioactivity curve, the synchrony (S) and entropy (E) parameters, have been developed and are generated by in house software. These parameters were demonstrated to be highly reproducible, with both intra-and inter-observer variability in the range of 2 percent (11) . Applied in a simulation model, S and E were observed to discriminate better the synchrony profiles among a spectrum of patterns of wall motion than LVEF or the standard deviation of LV phase angle (SDLVØ) measured on the phase histogram which plots Ø on the abscissa versus its frequency on the ordinate within the LV region of interest (ROI) (11) . The aim of this study was to correlate these novel parameters of S and E with clinical outcomes in patients with advanced HF undergoing CRT.
Methods
Background:
As previously reported from our laboratory (11) , with equilibrium radionuclide angiography, phase angle (Ø), and amplitude quantitate regional contraction timing and magnitude and are the basis for novel synchrony (S) and entropy (E) parameters. S is the vector sum of all amplitudes based on the angular distribution of Ø divided by the scalar sum of the length of all vectors. Complete S equals 1, and its absence equals 0. E measures the disorder in the region of interest, is 1 with random contraction and 0 with full synchrony, and differentiates among differing contraction patterns. S and E parameters were highly reproducible and well differentiated among patients with normal wall motion, aneurysm, diffuse dysfunction, and severe regional dysfunction. These novel indices of dyssynchrony were found superior to SD Ø (SD of ventricular phase) that failed to distinguish these groups of LV dysfunction (11).
Patient Population -All patients signed informed consent approved by the UCSF institutional review board. We evaluated 66 patients with systolic dysfunction, advanced HF, (NYHA Class III or IV), echocardiographic LVEF ≤35%, and QRS duration >120 ms, who were referred for CRT between February 2004 and October 2011. All patients received maximal tolerated medical therapy per their HF specialist (Table 1) .
Study Protocol -ERNA was performed one month or less before CRT implantation and after six months of CRT (Table 2 ) in order to assess serial changes of ventricular volumes, function, and synchrony. As part of the CRT evaluation all patients had serial 2-D echocardiograms within one month before CRT implantation and after 6 months of therapy with calculation of LVEF, LVEDVI and LVESVI. NYHA Class (12) of each patient before and after six months of CRT was determined by consensus of the HF specialist and cardiac electrophysiologist who were blinded to imaging results.
ERNA -Patients were injected with red blood cells labeled with technetium-99m by the "in vivtro" method (13) with an activity of approximately 20mCi/70kg body weight (11MBq/kg). Rest, supine, ECG gated anterior, "best septal" LAO and left lateral planar images were acquired in 16 frames, before and after CRT, using a Philips Forte camera (Philips Electronics, Inc., Milpitas, CA), processed by commercial software. LVS, LVE, SDLVØ, IVS, RVS, RVE, SDRVØ(see above)
were calculated, based on the phase image generated from the first harmonic fit of the ERNA time activity curve displayed by standard laboratory protocols (11, 14) .
First Harmonic Analysis and Synchrony Measures
In each ERNA pixel, the first harmonic curve fit is characterized by its phase and amplitude, representing surrogates for the timing and magnitude of regional contraction, respectively. For each pixel a harmonic vector can be drawn with direction representing its phase angle (Ø) from 0°, the ECG R wave gating signal, to 360°, and its length representing its amplitude (A). We developed the parameters of Synchrony (S) and Entropy (E), to express LV dyssynchrony, based on pixel Ø and A(11).
Definitions:
Established Parameters: Each calculated from the first harmonic phase histogram in the ventricular ROIs: SDLVØ; SDRVØ; IVS (Difference between mean LVS and RVS); LV Synchrony (S) and LV Entropy (E) are defined mathematically elsewhere (11, 14, 15) .
Synchrony (S)
LVS is a measure of contraction efficiency within the ERNA LV ROI, LVS, and is the vector sum of all amplitudes divided by their arithmetic sum.
S ranges from 0 to 1. With complete synchrony, vector numerator and arithmetic sum denominator, are equal and S = 1. S estimates the contraction potential if the ROI were synchronized. The maximum potential functional gain with CRT is 1 -S. 
Entropy (E)
LVE
Results
We enrolled 66 patients, 51 males (77.3%), mean age 62.9±13.9 years, each in sinus rhythm, 36(55%) with ischemic cardiomyopathy (Table 1) . 55 patients were NYHA III and 11 patients were NYHA IV. At 6-months post CRT implantation, 47(71%) patients, improved clinically. The 34 (51.5%) patients who improved by one NYHA class and the 13 (19.7%) who improved by two NYHA Classes were designated as responders, and the 19 (28.8%) who showed no change or worsened were designated as non-responders. Baseline age, sex, and cardiomyopathy etiology were not related to patient outcomes (Table 1) .
Predictive value of pre-CRT measures
Pre-implantation QRS duration, echocardiographic LVEF, LVEDVI, LVSVI, LVEF, and ERNA derived LVE, LVSDØ, RVSDØ, RVS and RVE could not distinguish response to CRT in these patients with class III and IV HF and echocardiographic EF <35%. Baseline LVS and IVS were the only parameters that predicted response to CRT ( Table 2) . CRT responders had lower group mean LVS (0.858 ± 0.12) compared to non-responders (0.915 ± 0.04, P=0.008), and higher IVS (18.3° ± 0.62 vs. 9.76° ± 9.69, P=0.009). 
Serial changes in post-CRT measures
The post-CRT change in QRS, echocardiographic and ERNA LVEF, LVS, LVE, LVSDØ, and IVS was significantly different between responders and nonresponders (Table 3) . Responders who improved two NYHA Classes revealed large improvements in these parameters. However, LVEF, LVSDØ, LVS and LVE change but not change in IVS could differentiate the highest responders from the non-responders and modest responders (Table 4) . RVSDØ, RVS, and RVE showed no significant change after CRT. 
Discussion
Main Findings
Although CRT improves ventricular synchrony and symptoms in many HF patients, as in this study, 30-40% do not benefit (2) (3) (4) (5) . In this study we serially measured established and novel quantitative ERNA parameters of ventricular dyssynchrony, and correlated them with clinical outcomes post-CRT among 66 patients with advanced HF. Given the high failure rate of electrocardiographic and echocardiographic parameters to CRT predict response in patients with advanced HF, an accurate and reproducible method to identify patients who benefit from CRT is needed. In this study pre-CRT IVS and LVS effectively identified CRT responders from non-responders.
Serial ERNA studies showed improvement in LVEF, LVS, LVE, SDLVØ and IVS, differed significantly between responders and non-responders. These characteristics show that both ventricular systolic function and synchrony improve with CRT. We present parameters for dyssynchrony measurement whose improvement correlates well with improved LVEF supporting the belief that improved intraventricular LV synchrony contributes to LVEF improvement post-CRT.
In this initial effort to evaluate the method, we have excluded patients with atrial fibrillation (AF) where the often rapid and irregular ventricular rates would produce artifacts in the data. However, scintigraphic methods could be applied to sample a limited fixed rate window, making the method applicable even in those with AF.
Comparison of Other Imaging Modalities
Imaging methods that capture the extent and sequence of ventricular contraction In this study we demonstrate the value of dyssynchrony derived from planar ERNA in predicting clinical outcomes after CRT implantation. Planar ERNA is relatively inexpensive, widely available and widely applied with high accuracy in virtually all patients (22). The sampling rate is sufficient to accurately measure LVEF (23) and temporal resolution is digitally enhanced and objectified by the generation of "parametric" images. The phase image has successfully tracked the sequence of ventricular wall motion in a variety of conduction abnormalities (15, 16, (20) (21) (22) (23) . The ability of planar ERNA phase analysis to assess myocardial synchrony is recognized (8, 12, (20) (21) (22) . The SDLVØ has demonstrated the influence of synchrony on HF and CRT outcomes and was the only parameter measured in sinus rhythm, which predicted VT intolerance (8, (20) (21) (22) (23) . ERNA is also the only imaging method that can evaluate adequately both LVS and IVS and their combined contribution to the CRT response in patients with advanced HF.
The potential value of SPECT ERNA was considered and we have now begun to acquire these studies in both planar and SPECT modes. We are now developing methods to calculate dyssynchrony parameters and others for the SPECT method.
SPECT imaging is also highly reproducible, repeatable, and widely available (7).
However, unlike planar ERNA, SPECT ERNA may lose accuracy due to undersampling with 8-frame acquisition, and routine 16-frame acquisition is recommended.
Comparison with ECG
QRS duration and morphology have been shown to be predictors of response to CRT (22-25). The CARE-HF study showed mortality benefit with CRT pacing alone in patients with LBBB morphology and QRS duration >150 ms (22-25).
Recent meta-analysis of CRT studies has shown that baseline QRS duration and image synchrony parameters is important and will serve to add validity to this preliminary assessment.
Conclusion
We have found novel measures of LV dyssynchrony derived from ERNA planar analysis (LVS and IVS) that predict clinical outcomes in HF patients undergoing CRT. These parameters appear promising in selection of patients most likely to respond to CRT with reduction of advanced heart failure over 6 months. Further study is required to demonstrate the reproducibility and correlation of ERNA derived measures of dyssynchrony on heart failure outcomes, and the cost effectiveness of this approach on patient selection for CRT. 
